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Open access under the ElLeishmaniasis and Chagas’ are parasitic protozoan diseases that affect the poorest population in the
world, causing a high mortality and morbidity. As a result of highly toxic and long-term treatments,
novel, safe and more efﬁcacious drugs are essential. In this work, the CH2Cl2 phase from MeOH extract
from the leaves of Baccharis retusa DC. (Asteraceae) was fractioned to afford two ﬂavonoids: naringenin
(1) and sakuranetin (2). These compounds were in vitro tested against Leishmania spp. promastigotes and
amastigotes and Trypanosoma cruzi trypomastigotes and amastigotes. Compound 2 presented activity
against Leishmania (L.) amazonensis, Leishmania (V.) braziliensis, Leishmania (L.) major, and Leishmania
(L.) chagasi with IC50 values in the range between 43 and 52 lg/mL and against T. cruzi trypomastigotes
(IC50 = 20.17 lg/mL). Despite of the chemical similarity, compound 1 did not show antiparasitic activity.
Additionally, compound 2 was subjected to a methylation procedure to give sakuranetin-40-methyl ether
(3), which resulted in an inactive compound against both Leishmania spp. and T. cruzi. The obtained
results indicated that the presence of one hydroxyl group at C-40 associated to one methoxyl group at
C-7 is important to the antiparasitic activity. Further drug design studies aiming derivatives could be a
promising tool for the development of new therapeutic agents for Leishmaniasis and Chagas’ disease.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The genus Baccharis, one of the most important genera of Aster-
aceae family, is widespread throughout Central and South America
(Nesom, 2000). Some of these species have been used in the folk
medicine to the treatment of stomach and liver diseases, to reduce
inﬂammatory processes and to cure ulcers and skin wounds (Melo
et al., 2001; Korbes, 1995; Corrêa, 1984; Franco, 1995; Bandoni
et al., 1978; Cortadi et al., 1999; Verdi et al., 2005). Previous chem-
ical studies on Baccharis species have been carried out and several
compounds such as terpenoids, tricotecenes, chromenes, and ﬂavo-
noids were found (Bohlmann et al., 1979; Labbe et al., 1986; Zdero
et al., 1989; Jarvis et al., 1991; Verdi et al., 2005; Grecco et al.,
2010a). Additionally, several works demonstrated that some of
these species have been sources of antileishmanial compounds,
mainly phenolics and triterpenoids (Fournet et al., 1994; da Silva
Filho et al., 2009; Zalewski et al., 2011).sevier OA license.Previous works have described that the Baccharis uncinella EtOH
extract as well as its main derivatives (oleanolic/ursolic acids, pect-
olinaringenin, caffeic acid, and ferulic acid) showed activity against
promastigotes and amastigotes forms of both Leishmania (L.) ama-
zonensis and Leishmania (V.) braziliensis (Passero et al., 2011). It was
also reported that 5,6,7-trihydroxy-40-methoxyﬂavanone, an iso-
lated derivative from MeOH extract of Baccharis retusa, showed
activity against cutaneous species of Leishmania (Grecco et al.,
2010b). In continuation with B. retusa investigation, the present
study was undertaken to determine the effects of main compounds
isolated from MeOH extract from the leaves of B. retusa against
Leishmania spp. and Trypanosoma cruzi: naringenin (1) and sakura-
netin (2). Additionally, sakuranetin-40-methyl ether (3) was pre-
pared after methylation of 2 and tested against the same parasites.
2. Materials and methods
2.1. General experimental procedures
Silica gel (Merck, 230–400 mesh) was used for column chro-
matographic separation, while silica gel 60 PF254 (Merck) was used
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corded, respectively, at 300 and 75 MHz in a Bruker DPX-300 spec-
trometer. CDCl3 (Aldrich) was used as solvent and TMS (Aldrich) as
internal standard. Chemical shifts are reported in d units (ppm) and
coupling constants (J) in Hz. LREIMS were measured in a HP 5990/
5988A mass spectrometer.
2.2. Plant material
Baccharis retusa DC. leaves were collected in Campos do Jordão,
SP, Brazil, in October 2008 and were identiﬁed by Dr. Oriana A.
Fávero. Voucher specimen has been deposited at Herbarium of
Instituto de Botânica-SEMA, São Paulo, SP, Brazil.
2.3. Extraction and isolation
Dried and powdered leaves of B. retusa (460 g) were exhaus-
tively defatted with hexane (at room temperature). Sequentially,
the plant material was extracted with MeOH (six times at room
temperature) affording 32 g of a syrupy green extract, after solvent
remotion under reduced pressure. This extract was partitioned be-
tween MeOH:H2O (1:2) and CH2Cl2. After evaporation under re-
duced pressure, the CH2Cl2 phase (13 g) was subjected to silica
gel column chromatography eluted with CH2Cl2 containing
increasing amounts of EtOAc (up to 100%) and with EtOAc contain-
ing increasing amounts of MeOH (up to 100%), to give 8 fractions
(A1–A8). Fraction A2 (3.6 g) was puriﬁed by silica gel column chro-
matography eluted with increasing amounts of EtOAc in CH2Cl2
(up to 100%) to afford 700 mg of 2. Fraction A4 (590 mg) was sub-
jected to silica gel column chromatography eluted with mixtures of
CH2Cl2:EtOAc:MeOH in gradient form to give 12 fractions (B1–
B12). Fraction B2 (142 mg) was puriﬁed by silica gel column chro-
matography eluted with CH2Cl2 containing increasing amounts of
EtOAc (up to 100%) and with EtOAc containing increasing amounts
of MeOH (up to 100%) to give 30 mg of 1.
2.4. 5,7,4’-Trihydroxy-ﬂavanone (naringenin-1)
1H NMR (300 MHz, CD3OD/DMSO-d6) dH: 7.27 (d, J = 8.5 Hz, H-
2’/H-6’), 6.82 (d, J = 8.5 Hz, H-3’/H-5’), 5.91 (s, H-6/H-8), 5.29 (dd,
J = 12.9 and 2.8 Hz, H-2), 3.06 (dd, J = 17.1 and 12.9, H-3a), 2.68
(dd, J = 17.1 and 2.8 Hz, H-3b). 13C NMR (75 MHz, CD3OD/DMSO-
d6) dC: 197.3 (C-4), 167.9 (C-9), 164.9 (C-7), 164.3 (C-4’), 158.4
(C-5), 130.4 (C-1’), 130.4 (C-6), 128.7 (C-2’/C-6’), 116.2 (C-3’/C-5’),
103.2 (C-10), 96.7 (C-8), 80.0 (C-2), 43.8 (C-3). LREIMS (70 eV) m/
z (int. rel.): 272 (100), 254 (6), 229 (5), 207 (4), 179 (20), 166
(28), 153 (83), 120 (81), 107 (27), 91 (35), 69 (35). 32 (60).
2.5. 5,4’-Dihydroxy-7-methoxyﬂavanone (sakuranetin-2)
1H NMR (300 MHz, CD3OD) dH: 7.26 (d, J = 8.5 Hz, H-2’/H-6’),
6.83 (d, J = 8.5 Hz, H-3’/H-5’), 6.01 (s, H-6/H-8), 5.32 (dd, J = 13.0
and 3.0 Hz, H-2), 3.77 (s, OCH3-7), 3.08 (dd, J = 17.2 and 13.0 Hz,
H-3a), 2.73 (dd, J = 17.2 and 3.0 Hz, H-3b). 13C NMR (75 MHz,
CD3OD) dC: 196.5 (C-4), 168.0 (C-4’), 163.6 (C-7), 163.0 (C-5),
157.4 (C-9), 129.0 (C-1’), 127.7 (C-2’/C-6’), 127.6 (C-6), 115.3 (C-
3’/C-5’), 102.8 (C-10), 93.9 (C-8), 79.1 (C-2), 55.3 (OCH3), 42.8 (C-
3). LREIMS (70 eV) m/z (int. rel.): 286 (67), 193 (33), 180 (39),
167 (100), 138 (24), 120 (44), 95 (38), 69 (25).
2.6. Preparation of sakuranetin-4’-methyl ether (3)
Compound 2 (100 mg, 0.35 mmol) was dissolved in CH2Cl2
(10 mL) and subjected to a methylation reaction driven by phase
transfer catalysis usingmethyl iodide (1.49 g, 9.9 mmol), potassium
carbonate (1 g, 7.23 mmol), and cetyltrimethyl ammoniumbromide(30 mg, 0.082 mmol). After 72 h at room temperature, the crude
product was extracted with CH2Cl2 (3  20 mL) and the organic
phasewas dried over anhydrous Na2SO4. Evaporation of solvent un-
der reduced pressure followed by puriﬁcation on CC using SiO2 and
n-hexane:EtOAc 3:2 as eluent afforded 3 (12 mg, 0.04 mmol).
2.7. 5-Hydroxy-7,4’-dimethoxyﬂavanone (sakuranetin 4’-methyl ether
- 3)
1H NMR (300 MHz, CDCl3) dH: 12.02 (s, OH-5), 7.37 (d, J = 8.7 Hz,
H-10/H-60), 6.94 (d, J = 8.7 Hz, H-20/H-50), 6.06 (d, J = 2.3 Hz, H-6),
6.03 (d, J = 2.3 Hz, H-8), 5.35 (dd, J = 12.9 and 3.0 Hz, H-2), 3.82
(s, OCH3-40), 3.79 (s, OCH3-7), 3.09 (dd, J = 17.1 and 13.0 Hz, H-
3b), 2.77 (dd, J = 17.1 and 3.0 Hz, H-3a). 13C NMR (75 MHz, CDCl3)
dC: 196.0 (C-4), 168.0 (C-7), 164.1 (C-5), 162.9 (C-9), 160.0 (C-40),
130.4 (C-10), 127.7 (C-20, 60), 114.2 (C-30, 50), 103.1 (C-10), 95.1
(C-6), 94.2 (C-8), 79.0 (C-2), 55.7 (OCH3-40), 55.4 (OCH3-7), 43.2
(C-3). LREIMS (70 eV) m/z (int. rel.): 300 (46), 282 (3), 207 (6),
193 (18), 166 (11), 134 (83), 121 (73), 108 (12), 91 (37), 65 (17),
32 (100).
2.8. Bioassays procedures
BALB/c mice and Golden hamsters were supplied by the animal
breeding facility at the Instituto Adolfo Lutz, São Paulo, and main-
tained in sterilized cages under a controlled environment, receiv-
ing water and food ad libitum. Animal procedures were
performed with the approval of the Research Ethics Commission,
in agreement with the Guide for the Care and Use of Laboratory
Animals from the National Academy of Sciences.
2.9. Parasite maintenance
Isolated promastigotes of L. (L.) amazonensis (WHO/BR/00/
LT0016), L. (V.) braziliensis (MHO/BR/75/M2903), Leishmania (L. )
chagasi (MHOM/BR/1972/LD) and Leishmania (L.) major (MHOM/
1L/80/Fredlin) were maintained in M-199 medium supplemented
with 10% calf serum and 0.25% hemin at 24 C. L. (L.) chagasi
(MHOM/BR/1972/LD) was maintained in hamsters (Mesocricetus
auratus). Amastigotes were harvested from spleens of infected
hamsters by differential centrifugation (Stauber, 1958). T. cruzi try-
pomastigotes (Y strain) were maintained in LLC-MK2 (ATCC CCL 7)
cells using RPMI-1640 medium supplemented with 2% calf serum
at 37 C.
2.10. Mammalian cells
Peritoneal macrophages were collected from the peritoneal cav-
ity of female BALB/c mice by washing with RPMI-1640 without
phenol red, supplemented with 10% fetal bovine serum. THP-1 (hu-
man monocytes ATCC number TIB-202) and kidney Rhesusmonkey
cells (LLC-MK2) were maintained in RPMI-1640 medium without
phenol red and supplemented with 10% fetal bovine serum at
37 C in a 5% CO2 humidiﬁed incubator (Corrêa et al., 2011).
2.11. Determination of the activity against Leishmania spp. –
promastigotes
To determine the 50% inhibitory concentration (IC50 value)
against Leishmania promastigotes, compounds 1–3were previously
dissolved in MeOH and diluted with M-199 medium in 96-well
microplates. Promastigotes were counted in a Neubauer hemocy-
tometer and seeded at 1  106/well with a ﬁnal volume of 150 lL.
Controls with MeOH and without drugs were also performed. Pent-
amidine was used as a standard drug. Top concentrations were
200 lg/mL for compounds 1–3 and 1.5 lg/mL for pentamidine
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luted over seven concentrations. Each point was tested in duplicate.
The plate was incubated for 24 h at 24 C and the viability of prom-
astigoteswas veriﬁed bymorphology in the lightmicroscopy and by
the MTT assay (Tempone et al., 2008). Brieﬂy, MTT (5 mg/mL) was
dissolved in PBS, sterilized through0.22 mmmembranes and added,
20 lL/well, for 4 h at 24 C. Promastigotes were incubated without
compounds and used as viability control. Formazan extraction was
performed using 10% SDS for 18 h (80 lL/well) at 24 C and the opti-
cal density (OD)was determined in aMultiskanMS (UNISCIENCE) at
550 nm. 100% viability was expressed based on the OD of control
promastigotes, after normalization.
2.12. Determination of the activity against Leishmania spp. -
intracellular amastigotes
Peritoneal macrophages were obtained as described previously
and L. (L.) chagasi (MHOM/BR/1972/LD) amastigotes were obtained
from spleens of infected hamsters by differential centrifugation.
Peritoneal macrophages were seeded at 4  105 cells per well in
13-mm glass cover slips in 24-well microplates for 24 h at 37 C
in a 5% CO2-humidiﬁed incubator. Amastigotes were added to mac-
rophages at 10:1 ratio (amastigotes:macrophage) and incubated
for 24 h. Test compounds were incubated for 120 h at the same
conditions. Glucantime was used as standard drug. Top concentra-
tions were 100 lg/mL for compounds 1–3 and 240 lg/mL for Glu-
cantime (based on dry weight) and the compounds were 2-fold
serially diluted over seven concentrations. Each point was tested
in duplicate. Finally, glass cover slips were ﬁxed with methanol,
stained with Giemsa, and observed in a light microscope. The num-
ber of amastigotes/macrophage was determined by counting 500
macrophages in each of the duplicates (Yardley et al., 2010).
2.13. Determination of the activity against T. cruzi - trypomastigotes
Compounds 1–3 were dissolved in MeOH and diluted in RPMI-
1640 medium to determine the 50% inhibitory concentration (IC50
value) as described above for the anti-leishmanial assay. Free try-
pomastigotes obtained from LLC-MK2 cultures were counted in a
Neubauer hemocytometer and seeded at 1  106/well in 96-well
microplates. Compounds 1–3 were incubated for 24 h at 37 C in
a 5% CO2 humidiﬁed incubator. Benznidazole was used as standard
drug. Top concentrations were 200 lg/mL for compounds 1–3 and
500 lg/mL for benznidazole (based on dry weight) and the com-
pounds were 2-fold serially diluted seven concentrations. Each
point was tested in duplicate. The viability of the trypomastigotes
was veriﬁed by the MTT assay as described above (Tada et al.,
1986; Lane et al., 1996).
2.14. Determination of the activity against T. cruzi – intracellular
amastigotes
The effect on T. cruzi intracellular amastigotes was performed in
macrophages previously infected with cell culture-derived try-
pomastigotes. Peritoneal macrophages were obtained as described
above. Cell culture-derived trypomastigotes were added to macro-
phages at 10:1 ratio (parasites/macrophage) and incubated for
24 h. Compounds 1–3 were incubated with parasites for 72 h at
37 C in a 5% CO2 humidiﬁed incubator. Top concentrations were
100 lg/mL for compounds 1–3 and 500 lg/mL for benznidazole
(based on dry weight) and 2-fold serially diluted over seven con-
centrations. Each point was tested in duplicate. In the end of the
assay, the glass cover slips were ﬁxed with methanol, stained with
Giemsa and observed in a light microscope. The parasite burden
was deﬁned as the mean number infected macrophages out of
200 cells (Silva et al., 2007).2.15. Determination of the cytotoxicity against mammalian cells
Rhesus monkey kidney cells (LLC-MK2) or THP-1 cells were
seeded at 4  104 cells/well in 96-well microplates and incubated
with compound 2 to the highest concentration of 500 lg/mL for
48 h at 37 C in a 5% CO2 humidiﬁed incubator. Top concentration
was 500 lg/mL for compound 2 (based on dry weight), which was
2-fold serially diluted over seven concentrations. The viability of
cells was determined by the MTT assay as described above. Glucan-
time, pentamidine, and benznidazole were used as standard drugs.
Control cells were incubated in the presence of MeOH and without
drugs.2.16. Statistical analysis
The data obtained represent the mean and standard deviation of
duplicate samples from two independent assays. The IC50 values
were calculated using sigmoid dose–response curves in Graph
Pad Prism 5.0 software, and the 95% conﬁdence intervals are in-
cluded in parentheses. The Mann–Whitney test was used for signif-
icance test (P value).3. Results and discussion
Baccharis species have been the source of several anti-parasitic
compounds, such as phenolic and terpenoids (da Silva Filho et al.,
2009). Our previous works reported the isolation of anti-leishman-
ial triterpenes and phenolic derivatives from B. uncinella (Passero
et al., 2011) as well as one ﬂavonoid from B. retusa (Grecco et al.,
2010b). As part of a continuous search, two ﬂavanones (1 and 2)
were isolated from B. retusa and characterized by analysis of its
spectroscopic data. The 1H NMR spectra of 1 and 2 showed signals
at d 5.29/5.32 (dd, J = 13.0 and 3.0 Hz), 3.06/3.08 (dd, J = 17.2 and
13.0 Hz), and at d 2.68/2.73 (dd, J = 17.2 and 3.0 Hz), assigned,
respectively, to H-2, H-3a, and H-3b (Danelutte et al., 2003). These
spectra showed also doublets attributed to H-30/H-50 at d 6.82/6.83
(J = 8.5 Hz, 2H) and to H-20/H-60 at d 7.27/7.26 (J = 8.5 Hz, 2H) as
well as one singlet assigned to H-6/H-8 at d 5.91/6.01 (2H). Addi-
tionally, in the spectrum of 2, was observed one singlet at d 3.77
(3H), assigned to one methoxyl group linked to C-7. Comparatively,
13C and DEPT 135 NMR spectra of 1 and 2 indicated the presence
of carbonyl carbons at d 197.3/196.5 (C-4), oxybenzylic carbons at
d 80.0/79.1 (C-2) and aliphatic carbons at d 43.8/42.8 (C-3). In the
spectrum of compound 2 was detected also an additional peak at d
55.3, assigned to methoxyl group at C-40. Remaining peaks at range
d94–168 were attributed to aromatic carbons C-5 to C-10 and C-10
to C-60. Comparison of spectroscopic data with those reported in
the literature (Agrawal, 1989), allowed the identiﬁcation of iso-
lated compounds as 5,7,40-trihydroxy-ﬂavanone (naringenin, 1)
and 5,40-dihydroxy-7-methoxy-ﬂavanone (sakuranetin, 2).
Aiming to discover preliminary structure–activity relationships,
part of compound 2 was subjected to methylation procedures,
affording 3. The 1H NMR spectrum of this compound showed sim-
ilarities of that recorded to compound 2, except to the presence of
one additional peak at d 3.82 (s, 3H), assigned to methoxyl group
linked to C-40. The position of this additional methyl group was
also conﬁrmed by LREIMS analysis due the fragments at m/z 166
(C8H6O4) and 134 (C9H10O), formed due to retro-Diels–Alder rear-
rangement. Comparison with spectral data with those described in
the literature (Agrawal, 1989; Silva et al., 2009), allowed the iden-
tiﬁcation of 3 as 5-hydroxy-7,40-dimethoxyﬂavanone (sakuranetin
40-methyl ether).
Flavanones 1–3 were tested against Cutaneous Leishmaniasis
species (L. (V.) braziliensis, L. (L.) amazonensis, and L. (L.) major)
and against a Visceral Leishmaniasis specie (L. (L.) chagasi). As
Table 1
Antiparasitic (antileishmanial and antitrypanossomal) and cytotoxic effects of ﬂavanones 1–3 and standard drugs.
Cell IC50 lg/mL (95% CI)
1 2 3 Standard drugs
L. (L.) chagasi promastigotes na 38.41* (30.06–49.13) 265.6* (213.9–329.7) 0.17a (0.09–0.22)
L. (L.) chagasi amastigotes na 43.66* (43.31–44.05) na 22.07b (18.74–26.38)
L. (L.) amazonensis promastigotes na 51.89* (39.31–69.98) na 0.040a (0.039–0.088)
L. (L.) major promastigotes na 52.60* (37.82–75.20) na 0.24a (0.18–0.27)
L. (V.) braziliensis promastigotes na 45.12* (37.01–55.33) na 0.13a (0.09–0.16)
T. cruzi trypomastigotes na 20.17* (18.80–21.73) na 42.45c (39.08–50.43)
T. cruzi amastigotes na na na >50
THP-1 cytotoxicity nd 39.50* (37.06–42.09) nd >100
LLC-MK2 cytotoxicity nd 25.97* (21.44–30.70) nd >100
IC50 – 50% inhibitory concentration (lg/mL); 95% CI – 95% conﬁdence interval; na – not active at 150 (promastigotes and trypomastigotes) or 300 lg/mL (amastigotes); nd –
not determined; standard drugs.
a Pentamidine.
b Glucantime.
c Benznidazole.
* P < 0.05 was compared to standard drugs.
144 S.d.S. Grecco et al. / Experimental Parasitology 130 (2012) 141–145showed in Table 1, ﬂavanone 1 was not active against Leishmania
and T. cruzi parasites to the highest concentration. Conversely, ﬂa-
vanone 2 showed activity against L. (L.) amazonensis, L. (V.) brazili-
ensis, and L. (L.) major with IC50 values of 51.89, 45.12, and
52.60 lg/mL, respectively. The obtained data also showed the
anti-leishmanial activity of compound 2 against L. (L.) chagasi
promastigotes, with an IC50 value of 38.41 lg/mL. By the MTT test,
it was possible to conﬁrm the leishmanicidal activity of com-
pounds after 24 h incubation, resulting in 100% of death to the
highest tested concentration. Considering the most relevant clini-
cal form of the parasite, compound 2 eliminated L. (L.) chagasi
intracellular amastigotes, with an IC50 value of 43.66 lg/mL after
120 h incubation. No toxicity to host cells could be detected as a
result of a normal morphology of peritoneal macrophages observed
by light microscopy. However, this compound showed a consider-
able toxicity to kidney cells LLC-MK2 and humanmonocytes THP-1
cells, with IC50 values of 25.97 and 39.50 lg/mL, respectively.
In order to evaluate the in vitro activity of the ﬂavonoids 1–3
against T. cruzi, these compounds were evaluated against trypom-
astigotes forms. Compound 2 presented activity against T. cruzi try-
pomastigotes, with an IC50 value of 20.17 lg/mL, killing 100% of
parasites after 24 h. As observed to Leishmania spp., compounds
1 and 3 did not show activity (Table 1) to the highest concentra-
tion. However, the obtained results to compound 2 demonstrates
that this ﬂavonoid is at least twofold more effective than the stan-
dard drug benznidazole, which resulted in an IC50 value of
47.50 lg/mL. Our results corroborate the anti-trypanosomal activ-
ity of sakuranetin (2) against T. cruzi trypomastigotes (Ribeiro
et al., 1997) and describe for the ﬁrst time the in vitro anti-leish-
manial activity of this ﬂavonoid.
Chemically, compounds 1 and 2 shows related structures (Fig. 1),
differing only by the substituent on C-7 at ring A. Considering thatR1O
OR2
1  R1 = R2 = H
2  R1 = CH3; R2 = H
3  R1 = CH3; R2 = CH3
Fig. 1. Chemical structures of ﬂavonoids 1–3.compound 1 presents a hydroxyl group at C-7 while 2 was substi-
tuted to methoxyl group as well, the effect of an additional methyl-
ation at B ring of 2was tested. Compound 3 (sakuranetin-4’-methyl
ether)was prepared and assayed against the sameparasites. The ob-
tained results indicated that, similarly as observed to compound 1,
neither anti-leishmanial nor anti-trypanosomal activity was de-
tected to compound 3, suggesting that co-occurrence of methoxyl
groups at C-7 andC-40 led to a reduction in the anti-parasitic activity.
Therefore, the occurrence of hydroxyl group at C-40 associated to the
presence methoxyl group at C-7 in related ﬂavanones is crucial to
anti-leishmanial or/and anti-trypanosomal activity.
Numerous plant-derived natural products from different struc-
tural classes including various alkaloids, ﬂavonoids, quinonoids,
and terpenoids, have been investigated as antileishmanial and anti-
trypanosomal candidates. Several works report the antikinetoplas-
tid activities of plant-derived natural products in the literature
(Akendengue et al., 1999; Fournet and Muñoz, 2002; Salem and
Werbovetz, 2006). Given the activities of these agents, natural prod-
ucts areapotentially richsourceofdrugcandidatesand leadsagainst
leishmaniasis and trypanosomiasis (Salem andWerbovetz, 2006).4. Conclusion
Flavonoids 1–3 were tested in vitro against Leishmania spp.
promastigotes and amastigotes and Trypanosoma cruzi trypom-
astigotes and amastigotes. Compound 2 presented activity against
L. (L.) amazonensis, L. (V.) braziliensis, L. (L.) major, and L. (L.) chagasi
and against T. cruzi trypomastigotes while compound 1 did not
show antiparasitic activity. Compound 2 was subjected to a meth-
ylation procedure to give sakuranetin-4’-methyl ether (3), which
resulted in an inactive compound against both Leishmania spp.
and T. cruzi. The obtained results indicated that the presence of
one hydroxyl group at C-4’ associated to one methoxyl group at
C-7 in related ﬂavonoids is important to the antiparasitic activity.
In conclusion, the present study provided useful information
about the structural features required for the anti-protozoan activ-
ity of these ﬂavonoids. This information could be used as a tool for
the design of novel and more efﬁcacious agents against Leishman-
iasis and Chagas’ disease.Acknowledgments
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